SEARCH

SEARCH BY CITATION

References

  • Adlersberg M., Arango V., Hsiung S. C., Mann J. J., Underwood M. D., Liu K. P., Kassir S. A., Ruggiero D. and Tamir H. (2000) In vitro autoradiography of serotonin 5-HT2A/2c receptor-activated G protein: guanosine-5′-(γ-[35S])thiotriphosphate binding in rat brain. J. Neurosci. Res. 61, 674685.
  • Andrade R., Malenka R. and Nicoll R. A. (1986) A G protein couples serotonin and GABA-B receptors to the same channels in hippocampus. Science 234, 12611265.
  • Arango V., Underwood M. D., Gubbi A. V. and Mann J. J. (1995) Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688, 121133.
  • Benes F. M., Kwok E. W., Vincent S. L. and Todtenkopf M. S. (1998) A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol. Psychiatry 44, 8897.
  • Cantley L. C. and Neel B. (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway. Proc. Natl Acad. Sci. USA 96, 42404245.
  • Carty D. J. (1994) Pertussis toxin-catalyzed ADP-ribosylation of G protein. Meth. Enzymol. 237, 6370.
  • Cheng A., Wang S., Yang D., Xiao R. and Mattson M. P. (2003) Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons. J. Biol. Chem. 278, 75917599.
  • Choi Y., Zhang J., Murga C. YuH., Koller E., Monia B. P., Gutkind J. S. and Li W. (2002) PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 21, 52895300.
  • Conti M., Richter W., Mehats C., Livera G., Park J. Y. and Jin C. (2003) Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem. 278, 54935496.
  • Cowburn R. F., Marcusson J. O., Eriksson A., Wiehager C. and O'Neill C. (1994) Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res. 633, 297304.
  • Cowen D. S., Sowers R. S. and Manning D. R. (1996) Activation of a mitogen-activated protein kinase (ERK2) by the 5-hydroxytryptamine1A receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis. J. Biol. Chem. 271, 2229722300.
  • De Vivo M. and Maayani S. (1987) Characterization of the 5-hydroxytryptamine 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238, 248253.
  • Della Rocca G. J., Mukhin Y. V., Garnovskaya M. N., Daaka Y., Clark G. J., Luttrell L., Lefkowitz R. and Raymond J. (1999) Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin dependent receptor endocytosis. J. Biol. Chem. 274, 47494753.
  • Dorph-Petersen K. A., Pierri J. N. and Lewis D. A. (2002) Volume and total neuron number of the primary visual cortex in schizophrenia. Neuroscience Abstract 28, Program no. 704.6.
  • Dowlatshahi D., MacQueen G. M., Wang J. F., Reiach J. S. and Trevor Young L. (1999) G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: Effect of diagnosis, suicide, and treatment at time of death. J. Neurochem. 73, 11211126.
  • Drevets W. C., Frank E., Price J. C., Kupfer D. J., Holt D., Greer P. J., Huang Y., Gautier C. and Mathis C. (1999) PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 46, 13751387.
  • Duman R. S., Heninger G. R. and Nestler E. J. (1997) A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54, 597606.
  • Dwivedi Y., Rizavi H. S., Roberts R., Conley R. C., Tamminga C. A. and Pandey G. N. (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J. Neurochem. 77, 916928.
  • Dwivedi Y., Conley R. R., Roberts R. C., Tamminga C. A. and Pandey G. N. (2002) [3H]cAMP binding sites and protein kinase A activity in the prefrontal cortex of suicide victims. Am. J. Psychiatry 159, 6673.
  • Evans K. L. J., Cropper J. D., Berg K. A. and Clarke W. P. (2001) Mechanisms of regulation of agonist efficacy at the 5-HT1A receptor by phospholipid-derived signaling component. J. Pharmacol. Exp. Ther. 297, 10251035.
  • Fields A., Li P. P., Kish S. J. and Warsh J. J. (1999) Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder. J. Neurochem. 73, 17041710.
  • Fillipa N., Sable C. L., Filloux C., Hemmings B. A. and Van Obberghen E. (1999) Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 19, 49895000.
  • Franke T. F., Kaplan D. R. and Cantley L. C. (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88, 435437.
  • Friedman E. and Wang H. W. (1996) Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J. Neurochem. 67, 11451152.
  • Fruman D. A., Meyers R. E. and Cantley L. C. (1998) Phosphoinositide kinases. Annu. Rev. Biochem. 67, 481507.
  • Gonzalez-Maeso J., Rodriguez-Puertas R., Meana J. J., Garcia-Sevilla J. A. and Guimon J. (2002) Neurotransmitter receptor-mediated activation of G-protein in brains of suicide victims with mood disorders: selective supersensitivity of α2A-adrenoreceptors. Mol. Psychiatry 7, 755767.
  • Guillard C., Chretien S., Pellus A. S., Porteu F., Muller O., Mayeux P. and Duprez V. (2003) Activation of the mitogen-activated protein kinases Erk1/2 by erythropoietin receptor via a Gi protein βγ-subunits-initiated pathway. J. Biol. Chem. 278, 1105011056.
  • Gutkind J. S. (1998) The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273, 18391842.
  • Hanoune J., Pouille Y., Tzavara E., Shen T., Lipskaya L., Miyamoto N., Suzuki Y. and Defer N. (1997) Adenylyl cyclase: structure, regulation and function in an enzyme superfamily. Mol. Cell. Endocrinol. 128, 179194.
  • Houslay M. D. and Kolch W. (2000) Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol. Pharmacol. 58, 659668.
  • Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. (1994) International Union of Pharmacology classification of receptors of 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157203.
  • Kandel E. S. and Hay N. (1999) The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253, 210229.
  • Kelly T. M. and Mann J. J. (1996) Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician antemortem diagnosis. Acta Psychiatr. Scand. 94, 337343.
  • Kim S., Jee K., Kim D., Koe H. and Chung J. (2001) Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J. Biol. Chem. 276, 1286412870.
  • Le Good J. A., Ziegler W. H., Parekh D. B., Alessi D. R., Cohen P. and Parker P. J. (1998) Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 20422045.
  • Li Y., Gonzalez M. I., Minkoth J. L., Field J., Kazanietz M. G. and Tennekoon G. I. (2003) Lysophosphatidic acid promotes survival and differentiation of the rat Schwann cells. J. Biol. Chem. 278, 95859591.
  • Liu K. P., Russo A., Hsiung S. C., Adlersberg M., Franke T. F., Gershon M. D. and Tamir H. (2003) Calcium receptor-induced serotonin secretion by parafollicular cells: role of phosphoinositol 3-kinase-dependent signal transduction pathways. J. Neurosci. 23, 20492057.
  • Lou L., Urban J., Ribeiro-Neto F. and Altschuler D. L. (2002) cAMP inhibition of Akt is mediated by activated and phosphorylated Rap1b. J. Biol. Chem. 277, 3279932806.
  • Lowther S., De Paermentier F., Cheetham S. C., Crompton M. R., Katona C. L. E. and Horton F. (1997) 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J. Affect. Disord. 42, 199207.
  • Manji H. K., Drevets W. and Charney D. (2001) The cellular neurobiology of depression. Nat. Med. 7, 541547.
  • Mann J. J. (1998) The neurobiology of suicide. Nat. Med. 4, 2529.
  • Mann J. J., Huang Y. Y., Underwood M. D., Kassir S. A., Oppenheim S., Kelly T. M., Dwork A. J. and Arango V. (2000) A serotonin transporter gene promotor polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry 57, 729738.
  • Mathews R., Li P. P., Young L. T., Kish S. J. and Warsh J. J. (1997) Increase Gaq/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder. Biol. Psychiatry 41, 649656.
  • Ongur D., Drevets W. and Price J. (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl Acad. Sci. USA 95, 1329013295.
  • Pacheco M. A., Stockmeier C., Meltzer H. Y., Overholserser J. C., Dilley G. E. and Jope R. S. (1996) Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res. 723, 3745.
  • Penington N. J., Kelly J. S. and Fow A. P. (1991) A study of the mechanism of Ca2+ current inhibition produced by serotonin in rat dorsal raphe neurons. J. Neurosci. 11, 35943609.
  • Perry E. K., Marshall E. F., Blessed G., Tomlinson B. E. and Perry R. H. (1983) Depressed imipramine binding in brains of patients with depressive illness. Br. J. Psychiatry 142, 188192.
  • Rahman S., Li P. P., Trevor Young L., Kofman O., Kish S. J. and Warsh J. J. (1997) Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J. Neurochem. 68, 297304.
  • Rajkowska G. (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glia cells. Biol. Psychiatry 48, 766777.
  • Rajkowska G., Miguel-Hidalgo J. J., Wei J., Dilley G., Pittman S. D., Meltzer H. Y., Overholser J. C., Roth B. L. and Stockmeier C. A. (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 45, 10851098.
  • Reiach J. S., Li P. P., Warsh J. J., Kish S. J. and Trevor Young L. (1999) Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims. J. Affect. Disord. 56, 141151.
  • Sanacora G., Mason G. F., Rothman D. L., Behar K. L., Hyder F., Petroff O. A. C., Berman R. M., Charney D. S. and Krystal J. H. (1999) Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56, 10431047.
  • Sargent P. A., Kjaer K. H., Bench C. J., Rabiner E. A., Messa C., Meyer J., Gunn R. N., Grasby P. M. and Cowen P. J. (2000) Brain serotonin 1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effect of depression and antidepressant treatment. Arch. Gen. Psychiatry 57, 174180.
  • Scheid M. P. and Woodgett J. R. (2001) PKB/Akt: functional insights from genetic models. Nat. Rev. Cell Biol. 2, 760768.
  • Serres F., Li Q., Garcia F., Raap D. K., Battaglia G., Muma N. A. and Van de Kar L. D. (2000) Evidence that G(z)-proteins couple to hypothalamic 5-HT1A receptors in vivo. J. Neurosci. 20, 30953103.
  • Stork P. J. S. and Schmitt J. M. (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12, 258266.
  • Touhara K., Hawes B. E., Van Biesen T. and Lefkowitz R. J. (1995) G protein βγ subunits stimulate phosphorylation of Shc adapter protein. Proc. Natl Acad. Sci. USA 92, 92849287.
  • Van Biesen T., Hawes B. E., Luttrell D. K., Krueger K. M., Touhara K., Porfiri E., Sakaue M., Luttrell L. M. and Lefkowitz R. J. (1995) Receptor-tyrosine-kinase-and G beta gamma-mediated MAP kinase activation by a common signaling pathway. Nature 376, 781784.
  • Vanhaesebroeck B., Leevers S., Panayotou G. and Waterfield M. (1997) Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22, 267272.
  • Yates M. and Ferrier I. (1990) 5-HT1A receptors in major depression. J Psychopharmacol. 4, 6974.
  • Young L. T., Li P. P., Kish S. J., Siu K., Kamble A., Hornykjewicz O. and Warsh J. J. (1993) Cerebral cortex Gαs protein levels and forskolin-stimulated cyclic AMP formation are increased in affective disorder. J. Neurochem. 61, 890898.
  • Zimmermann S. and Moelling K. (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 17411744.